ESC Premium Access

Initial combination therapy in pulmonary arterial hypertension: a new standard of care?

Event: ESC Congress 2018
Topic: Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
Session type: Satellite Symposium
Sponsored by GlaxoSmithKline
Date: 27 August 2018
Time: 13:00 - 14:00

Session

5 presentations in this session

Introduction - Initial combination therapy in PAH: A new standard of care?

Speaker: Professor J. Vachiery (Brussels, BE)
Thumbnail

Evolving management approaches in pulmonary arterial hypertension.

Speaker: Professor J. Vachiery (Brussels, BE)
Thumbnail

Initial combination therapy: Insights from clinical practice.

Speaker: Doctor M. D'Alto (Naples, IT)
Thumbnail

Putting guidelines into practice: Case study – Pulmonary Arterial Hypertension patient with cardiovascular co-morbidities.

Speaker: Doctor S. Gibbs (London, GB)
Thumbnail

Q&A - Initial combination therapy in pulmonary arterial hypertension: A new standard of care?

Speaker: Professor J. Vachiery (Brussels, BE)
Thumbnail

5 speakers from this session

Professor Jean-Luc Vachiery

Erasme Academic Hospital, Brussels (Belgium)
13 presentations
0 follower

Professor Jean-Luc Vachiery

Erasme Academic Hospital, Brussels (Belgium)
13 presentations
0 follower

Doctor Michele D'Alto

AORN Ospedali dei Colli - Monaldi Hospital, Naples (Italy)
3 presentations
0 follower

Doctor Simon Gibbs

Hammersmith Hospital, Imperial College London, NHLI, London (United Kingdom of Great Britain & Northern Ireland)
4 presentations
0 follower

Professor Jean-Luc Vachiery

Erasme Academic Hospital, Brussels (Belgium)
13 presentations
0 follower

This platform is supported by

logo Novo Nordisk